Please enable Javascript
Uromigos-Paper of the Month
Episode 262: Paper of the Month - Abiraterone +/- Cabazitaxel in CRPC
The Uromigos
The Uromigos
|
September 14, 2023
Dr. Susan F. Slovin discusses her recent paper that examined abiraterone with and without cabazitaxel for mCRPC.
Listen Now
The Uromigos Episode 169: Paper of the Month—Novel Neoadjuvant Approaches in UC
The Uromigos
The Uromigos
|
May 9, 2022
Syed Hussain and Sam Funt describe their studies on this topic.
Listen Now
The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data
The Uromigos
The Uromigos
|
April 6, 2022
Martin Stockler describes the ENZAMET trial, which shows mixed effects of enza on QOL in prostate cancer.
Listen Now
The Uromigos Episode 164: Paper of the Month—What Can We Learn from R3 Ipilimumab/Nivolumab in Gastric Cancer
The Uromigos
The Uromigos
|
April 1, 2022
Yelena Janjigian describes ipi/nivo versus nivo chemo versus chemo in gastric cancer.
Listen Now
The Uromigos Episode 152: Paper of the Month—Zr-Pembrolizumab PET Imaging
The Uromigos
The Uromigos
|
February 7, 2022
Elizabeth de Vries describes her paper on this topic published in Annals of Oncology.
Listen Now
The Uromigos Episode 148: Paper of the Month—Stereotactic Radiotherapy for Advanced Renal Cancer
The Uromigos
The Uromigos
|
December 21, 2021
Chad Tang discusses his oncology paper recently published in Lancet.
Listen Now
The Uromigos Episode 143: Paper of the Month—Determinants of Anti-PD-1 Response and Resistance in Clear Cell Renal Cell Carcinoma
The Uromigos
The Uromigos
|
November 17, 2021
Dr. Samra Turajlic describes her paper on clear cell renal cell carcinoma.
Listen Now
The Uromigos Episode 140: Ipilimumab in Renal Cancer
The Uromigos
The Uromigos
|
October 29, 2021
Dr. Mike Atkins discusses the role of CTLA4 inhibition in RCC.
Listen Now
The Uromigos Episode 139: Paper of the Month—Talazoparib in Biomarker-Positive Prostate Cancer
The Uromigos
The Uromigos
|
October 27, 2021
Dr. Tanya Dorff discusses the TALAPRO-1 study and the role of PARP inhibitors in prostate cancer.
Listen Now
The Uromigos Episode 125: Paper of the Month—MRI Screening for Prostate Cancer
The Uromigos
The Uromigos
|
August 27, 2021
Martin Eklund discusses his papers published in the New England Journal of Medicine and Lancet Oncology.
Listen Now
The Uromigos Episode 101: Paper of the Month—Belzutifan in Renal Cancer
The Uromigos
The Uromigos
|
May 26, 2021
Dr. Eric Jonasch gives an overview of his paper published in Nature Medicine.
Listen Now
The Uromigos Episode 97: Sacituzumab Govitecan
The Uromigos
The Uromigos
|
May 4, 2021
Dr. Petros Grivas discusses the accelerated approval of sacituzumab govitecan in bladder cancer.
Listen Now
The Uromigos Episode 93: Paper of the Month—A New Risk Classification for Germ Cell Cancer
The Uromigos
The Uromigos
|
April 14, 2021
Silke Gillessen discusses the back-to-back JCO papers on risk classification for germ cell cancer.
Listen Now
The Uromigos Episode 91: Paper of the Month—Adjuvant Atezolizumab in Bladder Cancer
The Uromigos
The Uromigos
|
March 26, 2021
Dr. Joaquim Bellmunt describes this study, as well as adjuvant nivolumab and ctDNA in bladder cancer.
Listen Now
The Uromigos Episode 89: Paper of the Month—Pembrolizumab in Clear Cell and Non-Clear Cell Renal Cancer
The Uromigos
The Uromigos
|
March 4, 2021
David McDermott describes back-to-back publications that examine pembrolizumab in clear cell and non-clear cell renal cancer.
Listen Now
The Uromigos Episode 77: Paper of the Month—Nadofaragene for BCG Unresponsive NMIBC
The Uromigos
The Uromigos
|
February 6, 2021
Dr. Stephen Boorjian outlines his non-muscle invasive bladder cancer paper published in Lancet.
Listen Now
The Uromigos Episode 68: Paper of the Month—Molecular Classification of Renal Cancer in Cancer Cell
The Uromigos
The Uromigos
|
December 8, 2020
Dr. Kim Rathmell discusses this paper, which divides clear cell renal cancer into seven relevant subgroups.
Listen Now
The Uromigos Episode 66: Paper of the Month—Two Papers in Nature Medicine on Neoadjuvant Immune Combinations in Bladder Cancer
The Uromigos
The Uromigos
|
November 9, 2020
Drs. Pam Sharma and Michiel Van Der Heijden discuss neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer.
Listen Now
The Uromigos Episode 62: Paper of the Month—James Eastham on Prostatectomy +/- Neoadjuvant Chemo
The Uromigos
The Uromigos
|
October 6, 2020
Dr. James Eastham describes this study, which gives insight into perioperative treatments for high-risk prostate cancer.
Listen Now
The Uromigos Episode 55: Paper of the Month—Cabozantinib in Bladder Cancer by Dr. Andrea Apolo
The Uromigos
The Uromigos
|
August 31, 2020
Dr. Andrea Apolo talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer.
Listen Now
Advertisement
Advertisement